BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,002,200 | -94.9% | 20,000 | +1930.5% | 0.34% | +66.5% |
| Q2 2022 | $19,500,000 | +2113.4% | 985 | -94.9% | 0.20% | +2.0% |
| Q1 2022 | $881,000 | -57.8% | 19,500 | 0.0% | 0.20% | -57.2% |
| Q4 2021 | $2,089,000 | +4.3% | 19,500 | 0.0% | 0.46% | -3.7% |
| Q3 2021 | $2,003,000 | +16.8% | 19,500 | 0.0% | 0.48% | +6.6% |
| Q2 2021 | $1,715,000 | -9.5% | 19,500 | 0.0% | 0.45% | -9.6% |
| Q1 2021 | $1,896,000 | -13.3% | 19,500 | 0.0% | 0.50% | -16.1% |
| Q4 2020 | $2,187,000 | +21.0% | 19,500 | 0.0% | 0.60% | +2.2% |
| Q3 2020 | $1,808,000 | +96.9% | 19,500 | +62.5% | 0.58% | +91.5% |
| Q2 2020 | $918,000 | +31.1% | 12,000 | 0.0% | 0.30% | -4.4% |
| Q1 2020 | $700,000 | -48.6% | 12,000 | -29.4% | 0.32% | -35.0% |
| Q4 2019 | $1,362,000 | +9.0% | 17,000 | 0.0% | 0.49% | -15.1% |
| Q3 2019 | $1,250,000 | -22.1% | 17,000 | 0.0% | 0.58% | -2.9% |
| Q2 2019 | $1,604,000 | – | 17,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |